Related Experiment Video
Updated: Aug 23, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Attitudes toward COVID-19 Vaccination: A Survey of Chinese Patients with Rheumatic Diseases
Zixi Yi1, Zhongqiang Yao1, Dan Xu1
1Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
Insights
Most patients with rheumatic diseases (RDs) in China want the COVID-19 vaccine, but few get it. Concerns about side effects and disease flares are key barriers. Rheumatologists need to improve vaccine education for these vulnerable patients.
Area of Science:
- Immunology
- Public Health
- Rheumatology
Background:
- The COVID-19 pandemic caused significant illness and death globally.
- Patients with rheumatic diseases (RDs) are at higher risk for severe COVID-19 due to immunocompromised status.
- COVID-19 vaccine acceptance is crucial for protecting vulnerable populations.
Purpose of the Study:
- To assess COVID-19 vaccine acceptance and identify barriers among patients with rheumatic diseases in China.
- To explore factors influencing vaccination willingness, including demographics, disease status, and information sources.
Main Methods:
- An online cross-sectional survey was conducted from May to October 2021.
- Data collected included attitudes toward COVID-19 vaccination, personal information, disease activity, adverse event concerns, and vaccine knowledge sources.
- Statistical analyses included descriptive statistics, nonparametric tests, and ordinal logistic regression.
Main Results:
- Out of 1022 respondents, 70.2% intended to get vaccinated, but only 31.6% were vaccinated.
- Positive vaccination attitudes were associated with male gender, employment, higher income, and inactive disease.
- Main barriers included concerns about adverse events and disease flare; only 29.6% felt adequately informed by their doctors.
Conclusions:
- A majority of Chinese patients with RDs expressed willingness to receive the COVID-19 vaccine, yet the actual vaccination rate remained low.
- Addressing concerns about adverse events and disease flares is essential to increase vaccine uptake.
- Rheumatologists play a vital role in enhancing patient education regarding COVID-19 vaccination for this high-risk group.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic has imposed enormous morbidity and mortality burdens. Patients with rheumatic diseases (RDs) are vulnerable to the COVID-19 infection, given their immunocompromised status. Ensuring acceptance of the COVID-19 vaccine is important and has attracted attention by health professionals. In this study, we designed an online cross-sectional survey that used an online questionnaire from 8 May 2021 to 4 October 2021. Attitudes toward the COVID-19 vaccination, personal information, current disease activity status, adverse events (AEs), and knowledge sources of vaccines were collected. Descriptive statistics, nonparametric tests, and ordinal logistic regression were used to analyze the data. A total of 1022 questionnaires were received, among which 70.2% (720/1022) of patients with RDs agreed to vaccination, while only 31.6% of patients were actually vaccinated. Male, employed, high-income patients and those with inactive disease showed a more positive attitude. Concerns of AEs and disease flare were the main factors affecting vaccination willingness. Only 29.6% (304/1022) of patients thought they had received enough information about the COVID-19 vaccine from their doctors. In conclusion, most patients with RDs in China intended to get vaccinated, although the vaccination rate in this particular population was low. Rheumatologists should take more responsibility in COVID-19 vaccination education of patients with RDs.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management
Vaccinations

